Navigation Links
MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease

dard of care."

The Phase 3 study was designed to compare the safety and efficacy of motavizumab with that of Synagis, which was first launched by MedImmune in 1998, in reducing serious RSV disease in high-risk infants in the inpatient and outpatient settings. As defined in the study, infants who are at high risk for RSV include those who were born at 35 weeks gestation or less as well as those who have chronic lung disease (CLD) due to being born prematurely. The primary endpoint was to assess the incidence of RSV hospitalizations with motavizumab compared to Synagis. Motavizumab met the primary endpoint, demonstrating non-inferiority to Synagis with 26 percent fewer RSV hospitalizations in motavizumab-treated infants. The overall RSV attack rate was low in both treatment groups: 1.4 percent for infants who received motavizumab, compared with 1.9 percent for those who received Synagis [RR: 0.740, 95 percent CI: (0.503, 1.083)]. The p-value for non-inferiority was p<0.01, demonstrating a significant finding.

Analysis of the data also showed that motavizumab reduced the incidence of RSV-specific medically attended outpatient LRIs (the study's RSV-related secondary endpoint) by approximately 50 percent compared with Synagis. The overall RSV-specific medically attended LRI rate was 2.0 percent for infants who received motavizumab compared with 3.9 percent for those who received Synagis (p<0.01). There were no significant differences in other non-RSV- specific endpoints.

"I am very pleased with the study results for motavizumab," said Xavier Carbonell, M.D., Ph.D., lead study author, chairman of neonatology, Barcelona Hospital Clinic, and vice president, Spanish Neonatal Society. "As a practicing neonatologist, I look forward to the potential to use this next- generation antibody to help reduce RSV-related hospitalizations and LRIs in the outpatient setting."

Data from this trial demonstrate that both study drugs were well tolerated. The incid
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
7. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
8. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
9. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:7/7/2015)... DUBLIN , June 30, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/mbgs4b/biomedical ) has announced the addition of ... report to their offering. ... in biomedicine. Photoacoustic imaging is a safe, ... several advantages and represents a great alternative ...
(Date:7/7/2015)... , July 7, 2015 According ... by Method (Manual, Automated), Product (Consumables, Instrument), Application (Aerobic, Anaerobic, ... Academic Research Institute) - Forecast to 2019", published by MarketsandMarkets, ... $3,893.5 Million by 2019 from $2,750.2 Million in 2014 at ... 1 78 ma rket ...
(Date:7/7/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/hmdflj/outlook_of_global ) ... Global Biologic Drug Discovery Outsourcing Market" report to ... outsourcing market will likely grow in a CAGR of ... B by 2020. It has been widely ... a new but important type of medication. They provide ...
Breaking Medicine Technology:Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 2Blood Culture Tests Market Worth $3,893.5 Million by 2019 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 4Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 2Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 3
... not always keep hands injury-freeLAS VEGAS, Feb. 27 ... on the rise in recent years, with more than ... Many of those injuries might be prevented with better ... the 2009 Annual Meeting of the American Academy ...
... Fenofibrate treatment reduces,cardiovascular disease (CVD) ... the,composite of cardiovascular death, myocardial infarction, ... patients with type 2 diabetes and,atherogenic ... high triglyceride (2.3,mmol/L-200mg/dL or higher) and ...
Cached Medicine Technology:Experience Not Always the Best Prescription for Snowblowers 2Experience Not Always the Best Prescription for Snowblowers 3Experience Not Always the Best Prescription for Snowblowers 4Diabetes Patients with High Triglycerides and Low HDL Cholesterol Get the Most Benefit From Fenofibrate Treatment: New Data From the FIELD Study 2Diabetes Patients with High Triglycerides and Low HDL Cholesterol Get the Most Benefit From Fenofibrate Treatment: New Data From the FIELD Study 3Diabetes Patients with High Triglycerides and Low HDL Cholesterol Get the Most Benefit From Fenofibrate Treatment: New Data From the FIELD Study 4Diabetes Patients with High Triglycerides and Low HDL Cholesterol Get the Most Benefit From Fenofibrate Treatment: New Data From the FIELD Study 5Diabetes Patients with High Triglycerides and Low HDL Cholesterol Get the Most Benefit From Fenofibrate Treatment: New Data From the FIELD Study 6
(Date:7/7/2015)... ... ... LAGOS, Nigeria – In her new novel, “ A Broken Rose ” (published ... who deals with abuse, alienation and torture from an impoverished and deeply religious village ... Nigeria and in a wealthy suburb of metropolitan Lagos, Nigeria, readers follow ...
(Date:7/7/2015)... ... July 07, 2015 , ... An ... Consultants that discussed how innovation and technology would be the “key factors” in ... address issues of accessibility and affordability, especially in emerging and growing markets. According ...
(Date:7/7/2015)... BELLINGHAM, WA (PRWEB) , ... July 07, 2015 , ... ... set to break ground as early as Summer 2015 on a four-acre site in ... dollar project, with the support of city officials and other members of the local ...
(Date:7/7/2015)... ... July 07, 2015 , ... More ... Sun Dial and Howdy’s, raised more than $524,286 during the Muscular Dystrophy ... nearly $100,000, to help support children fighting muscular dystrophy and related life-threatening ...
(Date:7/7/2015)... ... July 07, 2015 , ... A ... facial rejuvenation that have emerged about Hillary Clinton. Two plastic surgeons consulted by ... more youthful than she has in some time and speculate that she might ...
Breaking Medicine News(10 mins):Health News:Uju Amanambu crafts poignant tale depicting woes of mental illness 2Health News:Uju Amanambu crafts poignant tale depicting woes of mental illness 3Health News:Recent Article on Pharmaceutical Innovation Highlights the Need for Creative Solutions to Common Problems, Says Medlife Pharmacy 2Health News:Recent Article on Pharmaceutical Innovation Highlights the Need for Creative Solutions to Common Problems, Says Medlife Pharmacy 3Health News:New Silverado Memory Care Community Receives Unanimous Approval from Design Review Board 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3
... VIEW, Calif., Feb. 15 Concentric Medical,Inc., the global ... today announced the addition of Kimberly Bridges to its,management ... of a $15 million,line of credit., "We are ... Curtis, President and CEO of Concentric Medical. "Concentric is,entering ...
... Feb. 14 According to the National,Center for ... members will develop PTSD or other combat stress-related ... depression,trouble sleeping and other challenges within 60 to ... earlier or later. If left untreated, symptoms,could cause ...
... the recent findings of four Texas A&M University researchers could ... disease. , Diabetics not only have high blood glucose ... they have trouble metabolizing glucose and fatty acids. In the ... of diabetes separately because there was nothing linking them together. ...
... research, care , , THURSDAY, Feb. 14 (HealthDay News) -- ... deny they smoke when asked about it by doctors ... that analyzed data on 15,182 self-reported "nonsmokers" in the ... Health and Nutrition Examination Survey. The researchers found that ...
... Fulfill its Mission to Provide Dental Care to ... American Dental,Association (ADA) called on all concerned public ... Medicaid fulfill its mission to provide,dental care to ... statement provided today to the House Committee on ...
... WASHINGTON, Feb. 14 The American people,through the ... than $830,000 to the people of Tajikistan after ... a humanitarian crisis in the country. This,funding will ... services to those in need through USAID partners ...
Cached Medicine News:Health News:South Dakota Health Care Providers to Learn About PTSD at TriWest and VA-Sponsored Conference 2Health News:South Dakota Health Care Providers to Learn About PTSD at TriWest and VA-Sponsored Conference 3Health News:Research findings may lead to new ways to study and fight diabetes 2Health News:Research findings may lead to new ways to study and fight diabetes 3Health News:Older Smokers More Likely to Deny Habit 2Health News:ADA Calls for All Stakeholders to Work Together to Help Medicaid 2
Prevents contamination of RNA experiments commonly caused by latex gloves; made of Nitrile; these gloves are also certified free of Dnase...
This is the second generation of the famous A/O sliding microtome, manufactured in the United States under the Leica trademark....
... The MNL 440601 Small Sledge Microtome is ideal ... dental or skin specimens. Specimen rise is ... 2 30 microns in increments of 2 ... Freezing Stages.,Other Associated Products, Vibratomes Freezing ...
... The Professional Gold Package is ... laboratory. The package includes the ... automated system, standard accessory kit, ... specimen mounts 1/2" head, rotating ...
Medicine Products: